Blog
Lincoln Electric (LECO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Lincoln Electric Holdings (LECO) reported $1.06 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 7.9%. EPS of $2.47 for the same period compares to
Earnings Preview: Hyatt Hotels (H) Q3 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Hyatt Hotels (H) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Itron (ITRI) Reports Q3 Earnings: What Key Metrics Have to Say
Itron (ITRI) reported $581.63 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 5.5%. EPS of $1.54 for the same period compares to $1.84 a year ago.
Upbound Group (UPBD) Reports Q3 Earnings: What Key Metrics Have to Say
Upbound Group (UPBD) reported $1.16 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 9%. EPS of $1.00 for the same period compares to $0.95 a year
MasterCard (MA) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended September 2025, MasterCard (MA) reported revenue of $8.6 billion, up 16.7% over the same period last year. EPS came in at $4.38, compared to $3.89 in the year-ago quarter.
The
APi (APG) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended September 2025, APi (APG) reported revenue of $2.09 billion, up 14.2% over the same period last year. EPS came in at $0.41, compared to $0.34 in the year-ago quarter.
The
Hilton Grand Vacations (HGV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Hilton Grand Vacations (HGV) reported $1.3 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.5%. EPS of $0.60 for the same period compares to $0.67
First Foundation (FFWM) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended September 2025, First Foundation (FFWM) reported revenue of $63.6 million, up 4.2% over the same period last year. EPS came in at $0.16, compared to $0.04 in the year-ago
Roblox (RBLX) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended September 2025, Roblox (RBLX) reported revenue of $1.92 billion, up 70.3% over the same period last year. EPS came in at -$0.37, compared to -$0.37 in the year-ago quarter.
The
Compared to Estimates, Shake Shack (SHAK) Q3 Earnings: A Look at Key Metrics
Shake Shack (SHAK) reported $367.41 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.9%. EPS of $0.36 for the same period compares to $0.25 a
Kimco Realty (KIM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Kimco Realty (KIM) reported revenue of $535.86 million, up 5.6% over the same period last year. EPS came in at $0.44, compared to $0.19 in the year-ago quarter.
LCI (LCII) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, LCI (LCII) reported revenue of $1.04 billion, up 13.2% over the same period last year. EPS came in at $1.97, compared to $1.39 in the year-ago quarter.
The
Best Momentum Stock to Buy for Oct. 30th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 30th:
Corning GLW: This company, which developed its glass technologies to produce
Wall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade
Shares of Ocular Therapeutix (OCUL) have gained 4% over the past four weeks to close the last trading session at $11.48, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Here's is How to Trade
Shares of Apogee Therapeutics Inc. (APGE) have gained 41.4% over the past four weeks to close the last trading session at $55.7, but there could still be a solid upside left in the stock if
Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet
Shares of Relay Therapeutics, Inc. (RLAY) have gained 37.4% over the past four weeks to close the last trading session at $7.31, but there could still be a solid upside left in the stock if
Wall Street Analysts Predict a 27.2% Upside in James Hardie (JHX): Here's What You Should Know
Shares of James Hardie (JHX) have gained 8.5% over the past four weeks to close the last trading session at $21.36, but there could still be a solid upside left in the stock if short-term price
LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for LENZ Therapeutics, Inc. (LENZ) has been bearish lately and the stock has lost 6.3% over the past week. However, the formation of a hammer chart pattern in its last trading
Wall Street Analysts Believe Kamada (KMDA) Could Rally 113.15%: Here's is How to Trade
Shares of Kamada (KMDA) have gained 1.2% over the past four weeks to close the last trading session at $6.92, but there could still be a solid upside left in the stock if short-term price targets of
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?
Shares of Day One Biopharmaceuticals, Inc. (DAWN) have gained 2.3% over the past four weeks to close the last trading session at $7.04, but there could still be a solid upside left in the stock if
OppFi (OPFI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for OppFi Inc. (OPFI) has been bearish lately and the stock has lost 7.4% over the past four weeks. However, the formation of a hammer chart pattern in its last trading session
Company News for Oct 30, 2025
- Shares of The Boeing Company (BA) declined 4.4% after the company reported third-quarter 2025 loss of $7.47 per share, wider than the Zacks Consensus Estimate of a loss of $3.85.
- Shares of
Why Marathon Petroleum (MPC) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates


